White Paper
Technology disruption in the IVD arena
Sep 11, 2020

As new technologies change the way IVDs are used, labs are evolving from clinical data providers to insight engines that drive clinical decision-making. In vitro testing results now influence up to 70% of clinical decisions, and that number is growing. Whether through new technologies, new partnerships or a combination of measures, IVD players, labs and care providers have a chance to tap new technologies and new data to improve patient engagement, care delivery and, most important, health outcomes. This executive summary of our recent webinar discusses how the anticipated integration of next generation hardware, biomarkers, and sensors will drive change in the current laboratory landscape and how the role of artificial intelligence tools will evolve.

Contact Us